EUVIMEDEUVIMED entdecken
Editorial

Gene Therapy to Treat Profound Hearing Loss

Paul Van de Heyning iD, Vincent Van Rompaey

New England Journal of Medicine · 12.03.2026 · 394 (11) · 1126-1130

DOI: 10.1056/nejme2514326 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 12.03.2026. Verfasst von Paul Van de Heyning und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium.
  • Resonant Labs Antwerp, Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Paul Van de Heyning

Zitieren

APA

Van de Heyning, P., & Van Rompaey, V. (2026). Gene Therapy to Treat Profound Hearing Loss. New England Journal of Medicine, 394(11), 1126-1130. https://doi.org/10.1056/nejme2514326

Vancouver

Van de Heyning P, Van Rompaey V. Gene Therapy to Treat Profound Hearing Loss. New England Journal of Medicine. 2026;394(11):1126-1130. doi:10.1056/nejme2514326

BibTeX
@article{VandeHeyning2026,
  author = {Van de Heyning, Paul and Van Rompaey, Vincent},
  title = {Gene Therapy to Treat Profound Hearing Loss},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {11},
  pages = {1126--1130},
  doi = {10.1056/nejme2514326}
}
Kostenlos starten →